Peer-influenced content. Sources you trust. No registration required. This is HCN.

HealthlineMounjaro, Zepbound: What Happens to Your Body When You Stop Taking Weight Loss Drugs

Understanding the Biological and Psychological Implications of Discontinuing GLP-1 Weight Loss Drugs and Their Potential Impact on Clinical Practice

Stopping GLP-1 drugs like Mounjaro and Zepbound can lead to significant biological and psychological changes, including weight regain, increased appetite, and mood alterations. These medications, while effective for managing weight and blood glucose levels, are not meant for short-term use. Physicians should be aware of the potential challenges patients may face upon discontinuation and the importance of proper medical guidance during this transition.

Key Points:

  • Weight Regain: Patients often experience weight regain after stopping GLP-1 drugs, with studies showing a significant percentage of weight lost being regained within a year.
    • A 2023 study reported participants regaining 14% of weight lost after stopping tirzepatide.
    • A 2022 trial indicated two-thirds of weight lost on semaglutide was regained within a year of cessation.
  • Appetite Increase: Discontinuing GLP-1 drugs leads to a return of pre-treatment appetite levels, causing increased food intake and potential stomach stretching.
    • Tirzepatide’s action on GIP and GLP-1 receptors, which slow stomach emptying and promote satiety, ceases, resulting in increased hunger.
  • Biological Mechanisms: GLP-1 and GIP receptor agonists stimulate insulin secretion, increase insulin sensitivity, and control blood sugar, but these effects are not permanent.
    • Upon discontinuation, the body’s weight-promoting mechanisms resume, leading to weight regain.
  • Psychological Changes: Stopping GLP-1 drugs can lead to mood changes, with some patients experiencing increased anxiety or depression due to weight regain and heightened hunger.
    • Conversely, some individuals may feel better mentally after stopping the medication, especially if they experienced negative mood effects while on it.
  • Taste Sensitivity: Although not well-documented, there are anecdotal reports of changes in taste perception after stopping GLP-1 drugs.
    • The complex neurological process involving taste may be influenced by GLP-1 receptors found along taste pathways.
  • Insulin Spikes: Discontinuing tirzepatide can lead to blood glucose spikes if the body cannot produce sufficient insulin without the medication.
    • The primary benefit of these drugs for diabetes management is their ability to help with insulin levels and blood sugar control.
  • GI Side Effects: Gastrointestinal discomforts such as nausea and diarrhea may occur both during and after the discontinuation of GLP-1 drugs.
    • These side effects generally subside within a month after stopping the medication, but persistent symptoms should be discussed with a healthcare provider.

“When coming off any medication, it is essential to talk to your healthcare provider to understand the changes that may occur within your body. Many medications are safe to quit cold turkey, while certain medications require careful tapering to avoid unpleasant withdrawal effects or even harmful outcomes.”
– HaVy Ngo-Hamilton, PharmD

More on Obesity/Weight Management

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form